Furthermore, 66% of patients with APC/CTNNB1 genetic aberrations developed brain metastases within six months from the original diagnosis of MM compared to 45% of patients without; however, the time-to-development brain metastases was not significantly different between the two groups (data not shown). This evidence concerns the gene CTNNB1 and Miyoshi myopathy.